Evidence map›Paper›PMID 36324496›Full record

ArticleRSC medicinal chemistry2022

Oleic amide derivatives as small molecule stimulators of the human proteasome's core particle.

Saayak Halder, Nathaniel J Macatangay, Breanna L Zerfas, Andres F Salazar-Chaparro, Darci J Trader

Abstract read
In one paragraph

Article in RSC medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Discovery and Development of Cyclic Peptide Proteasome Stimulators.Chembiochem : a European journal of chemical biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Saayak HalderDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University 575 W Stadium Ave West Lafayette IN 47907 USA dtrader@purdue.edu.ORCID https://orcid.org/0000-0002-0445-8903
Nathaniel J MacatangayDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University 575 W Stadium Ave West Lafayette IN 47907 USA dtrader@purdue.edu.
Breanna L ZerfasDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University 575 W Stadium Ave West Lafayette IN 47907 USA dtrader@purdue.edu.
Andres F Salazar-ChaparroDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University 575 W Stadium Ave West Lafayette IN 47907 USA dtrader@purdue.edu.
Darci J TraderDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University 575 W Stadium Ave West Lafayette IN 47907 USA dtrader@purdue.edu.ORCID https://orcid.org/0000-0002-0607-1243

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI Andrea L Kasinski · 1985 to 2026
$43.4M
Development of Activity-Based Chemical Reporters to Differentiate Proteasome Isoforms in CellsR21GM131206 · NIGMS · PURDUE UNIVERSITY · PI TRADER, DARCI J · 2019 to 2020
$426k
NCI NIH HHS P30 CA023168NIGMS NIH HHS R21 GM131206
6 · The paper itself

Abstract

A series of oleic acid amide derivatives were synthesized based on our previous and continuing endeavors towards stimulation of the 20S core particle of the proteasome (20S CP) with the goal of increasing the protein degradation rate

Identifiers

PMID36324496
PMCPMC9491356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.